AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2018
Nov 14, 2018
34129_dirs_2018-11-14_03e9b42c-587f-41e2-b3f4-bdc544039482.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-11-13
Reporting Person: Koenig Scott (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-13 | Common Stock | M | 40000 | $0.94 | Acquired | 173163 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-13 | Employee stock option (right to buy) | $0.94 | M | 40000 | Disposed | 2019-01-10 | Common Stock (40000.0) | Direct |
Footnotes
F1: The transaction represents an exercise and hold of expiring options.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18